[The effect of thiophosphamide on the glycogenetic and absorption-excretory function of the liver in patients with malignant tumors].
D000042:Absorption; D001786:Blood Glucose; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D005690:Galactose / Q000378:metabolism; D006029:Glycosuria; D006801:Humans; D007457:Iodine Radioisotopes; D008099:Liver / Q000187:drug effects*; D008112:Liver Glycogen / Q000096:biosynthesis*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013852:Thiotepa / Q000009:adverse effects*
D001786:Blood Glucose; D007457:Iodine Radioisotopes; D008112:Liver Glycogen; D013852:Thiotepa; D005690:Galactose
Vliianie tiofosfamida na glikogenoobrazovatel'nuiu i poglotitel'no-vydelitel'nuiu funktsii pecheni bol'nykh zlokachestvennymi opukholiami.